glp-1 drugs uses Medications: Everything You Need to Know Weight loss drugs don't work

There was a slightly higher rate of gallbladder disorders in the semaglutide group (2.8% vs

FDA has issued a box warning of the risk of thyroid cancers and are contraindicated liraglutide, exenatide (once weekly), and semaglutide (both oral and injectable) in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia types 2 A or 2B [135, 136]

The outcomes of this exploratory pooled analysis provide a level of reassurance regarding the suicidal safety associated with the use of liraglutide 3.0 mg in patients who share similarities with those involved in the examined trials

Abstract Aim We aimed to assess the association between the use of Glucagon-like peptide-1 receptor agonists and the risk of 12 respiratory diseases in patients with type 2 diabetes, obesity, or overweight

Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines